Equities

Bioventix PLC

BVXP:LSE

Bioventix PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4,375.00
  • Today's Change0.00 / 0.00%
  • Shares traded322.00
  • 1 Year change17.45%
  • Beta0.2739
Data delayed at least 20 minutes, as of May 15 2024 15:46 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
ASSETS
Cash And Short Term Investments5.726.136.49
Total Receivables, Net1.170.760.65
Total Inventory0.570.460.33
Prepaid expenses4.644.463.98
Other current assets, total------
Total current assets121211
Property, plant & equipment, net0.580.690.84
Goodwill, net------
Intangibles, net------
Long term investments0.610.610.61
Note receivable - long term------
Other long term assets------
Total assets131313
LIABILITIES
Accounts payable0.080.160.15
Accrued expenses0.410.390.32
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0.710.710.54
Total current liabilities1.201.251.01
Total long term debt000
Total debt000
Deferred income tax0.020.040.08
Minority interest------
Other liabilities, total------
Total liabilities1.221.301.09
SHAREHOLDERS EQUITY
Common stock0.260.260.26
Additional paid-in capital1.471.331.33
Retained earnings (accumulated deficit)101010
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity121212
Total liabilities & shareholders' equity131313
Total common shares outstanding5.225.215.21
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.